Mario U. Mondelli

14.7k total citations
205 papers, 8.1k citations indexed

About

Mario U. Mondelli is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Mario U. Mondelli has authored 205 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Hepatology, 109 papers in Epidemiology and 48 papers in Immunology. Recurrent topics in Mario U. Mondelli's work include Hepatitis C virus research (124 papers), Hepatitis B Virus Studies (75 papers) and Liver Disease Diagnosis and Treatment (63 papers). Mario U. Mondelli is often cited by papers focused on Hepatitis C virus research (124 papers), Hepatitis B Virus Studies (75 papers) and Liver Disease Diagnosis and Treatment (63 papers). Mario U. Mondelli collaborates with scholars based in Italy, United States and United Kingdom. Mario U. Mondelli's co-authors include Antonella Cerino, Enrico Maria Silini, Savino Bruno, Stefania Varchetta, A L Eddleston, Barbara Oliviero, Agostino Cividini, R. Williams, Vincenzo Barnaba and Fulvia Bono and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Mario U. Mondelli

200 papers receiving 7.8k citations

Peers

Mario U. Mondelli
Lawrence M. Blatt United States
K A Fleming United Kingdom
Robert G. Gish United States
Thomas R. OʼBrien United States
Beat Müllhaupt Switzerland
Lawrence M. Blatt United States
Mario U. Mondelli
Citations per year, relative to Mario U. Mondelli Mario U. Mondelli (= 1×) peers Lawrence M. Blatt

Countries citing papers authored by Mario U. Mondelli

Since Specialization
Citations

This map shows the geographic impact of Mario U. Mondelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario U. Mondelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario U. Mondelli more than expected).

Fields of papers citing papers by Mario U. Mondelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario U. Mondelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario U. Mondelli. The network helps show where Mario U. Mondelli may publish in the future.

Co-authorship network of co-authors of Mario U. Mondelli

This figure shows the co-authorship network connecting the top 25 collaborators of Mario U. Mondelli. A scholar is included among the top collaborators of Mario U. Mondelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario U. Mondelli. Mario U. Mondelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mele, Dalila, Andrea Lombardi, Alessandra Bandera, et al.. (2024). Long‐term dynamics of natural killer cells in response to SARS‐CoV‐2 vaccination: Persistently enhanced activity postvaccination. Journal of Medical Virology. 96(4). e29585–e29585. 5 indexed citations
2.
Mantovani, Stefania, Barbara Oliviero, Stefania Varchetta, Alessandra Renieri, & Mario U. Mondelli. (2023). TLRs: Innate Immune Sentries against SARS-CoV-2 Infection. International Journal of Molecular Sciences. 24(9). 8065–8065. 36 indexed citations
3.
Marjot, Thomas, Christiane S. Eberhardt, Tobias Boettler, et al.. (2022). Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper. Journal of Hepatology. 77(4). 1161–1197. 43 indexed citations
4.
Boettler, Tobias, Philip N. Newsome, Mario U. Mondelli, et al.. (2020). Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Reports. 2(3). 100113–100113. 346 indexed citations
5.
Lombardi, Andrea, Marta Colaneri, Margherita Sambo, et al.. (2020). Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing?. Digestive and Liver Disease. 53(4). 456–460. 1 indexed citations
6.
Aboal, Diego, et al.. (2018). Innovation and productivity in agricultural firms: evidence from a country-wide farm-level innovation survey. Economics of Innovation and New Technology. 28(6). 616–634. 13 indexed citations
7.
Lombardi, Andrea, Simona Landonio, C. Magni, et al.. (2015). <b><i>ITPA</i></b> and <b><i>SLC29A1</i></b> Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors. Pharmacology. 96(3-4). 163–166. 1 indexed citations
8.
Fagiuoli, S., Agostino Colli, Raffaele Bruno, et al.. (2014). Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference. Journal of Hepatology. 60(5). 1075–1089. 74 indexed citations
9.
Okolicsanyi, S., Manuel Gentiluomo, Paolo Angelo Cortesi, et al.. (2013). Generation and Performance of Outcome Indicators in Liver Disease: The Value Based Medicine in Hepatology Study (VBMH). Hepatology. 58. 2 indexed citations
10.
Oliviero, Barbara, Stefania Varchetta, G Michelone, et al.. (2009). Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections. Gastroenterology. 137(3). 1151–1160.e7. 335 indexed citations
11.
Oliviero, Barbara, Stefania Varchetta, Antonella Cerino, et al.. (2008). 115 ENHANCED NK CELL CYTOLYTIC ACTIVITY IN CHRONIC HCV INFECTION. Journal of Hepatology. 48. S51–S51. 1 indexed citations
12.
Varchetta, Stefania, Barbara Oliviero, F. Agnelli, et al.. (2008). Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation. Journal of Hepatology. 50(2). 314–322. 15 indexed citations
13.
Accapezzato, Daniele, Vincenzo Visco, Vittorio Francavilla, et al.. (2005). Chloroquine enhances human CD8 + T cell responses against soluble antigens in vivo. The Journal of Experimental Medicine. 202(6). 817–828. 180 indexed citations
14.
Accapezzato, Daniele, Vittorio Francavilla, Marino Paroli, et al.. (2004). Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection. Journal of Clinical Investigation. 113(7). 963–972. 13 indexed citations
15.
Mondelli, Mario U., Antonella Cerino, Annalisa Meola, & Alfredo Nicosia. (2003). Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses. Journal of Biosciences. 28(3). 305–310. 14 indexed citations
16.
Cerino, Antonella, Annalisa Meola, Milena Furione, et al.. (2001). Monoclonal Antibodies with Broad Specificity for Hepatitis C Virus Hypervariable Region 1 Variants Can Recognize Viral Particles. The Journal of Immunology. 167(7). 3878–3886. 28 indexed citations
17.
Maccabruni, Anna, Grazia Bossi, Desireé Caselli, et al.. (1995). High efficiency of vertical transmission of hepatitis C virus among babies born to human immunodeficiency virus-negative women: To the Editors. The Pediatric Infectious Disease Journal. 14(10). 1 indexed citations
18.
Mondelli, Mario U., Agostino Cividini, & Antonella Cerino. (1995). Role of humoral immune responses in hepatitis B and C virus infections. European Journal of Clinical Investigation. 25(8). 543–547. 2 indexed citations
19.
Mondelli, Mario U., Giorgina Mieli‐Vergani, A L Eddleston, Roger Williams, & A P Mowat. (1984). Lymphocyte cytotoxicity to autologous hepatocytes in alpha 1-antitrypsin deficiency.. Gut. 25(10). 1044–1049. 13 indexed citations
20.
Eddleston, A L, Mario U. Mondelli, Giorgina Mieli‐Vergani, & R. Williams. (1982). Lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection. Hepatology. 2. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026